Pelthos Therapeutics Files Amended Ownership Report
Ticker: PTHS · Form: 4/A · Filed: 2026-04-01T17:44:11-04:00
Sentiment: neutral
Topics: insider-ownership, amendment, sec-filing
TL;DR
Pelthos Therapeutics filed a 4/A amendment for ownership changes. Check it out.
AI Summary
Pelthos Therapeutics Inc. filed an amended Form 4/A on April 1, 2026, to report changes in beneficial ownership of securities. The filing pertains to the period of report ending July 2, 2025. The company is involved in Biological Products, excluding Diagnostic Substances.
Why It Matters
This amended filing provides updated information on the beneficial ownership of Pelthos Therapeutics' securities, which is crucial for investors to understand insider holdings and potential trading activities.
Risk Assessment
Risk Level: low — A 4/A filing is an amendment to a previous filing and typically involves corrections or updates, not new material events.
Key Players & Entities
- Pelthos Therapeutics Inc. (company) — Issuer
- 0001919246 (company) — CIK
- Plesha Scott M. (person) — Reporting Person
- 0001726687 (person) — CIK of Reporting Person
- 2026-04-01 (date) — Filing Date
- 2025-07-02 (date) — Period of Report
FAQ
What type of filing is this and when was it filed?
This is an amended Form 4/A filing, accepted on April 1, 2026.
What is the period of report for this filing?
The period of report for this filing is July 2, 2025.
Who is the issuer and what is their CIK number?
The issuer is Pelthos Therapeutics Inc. with CIK number 0001919246.
Who is listed as the reporting person and what is their CIK?
Plesha Scott M. is listed as the reporting person with CIK 0001726687.
What industry does Pelthos Therapeutics Inc. operate in?
Pelthos Therapeutics Inc. operates in Biological Products, (No Diagnostic Substances).
From the Filing
EDGAR Filing Documents for 0001919246-26-000044 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] SEC Accession No. 0001919246-26-000044 Filing Date 2026-04-01 Accepted 2026-04-01 17:44:11 Documents 2 Period of Report 2025-07-02 Document Format Files Seq Description Document Type Size 1 FORM 4/A wk-form4a_1775079846.html 4/A 1 FORM 4/A wk-form4a_1775079846.xml 4/A 4806 2 EX-24 pths-section16_poaxv5xples.htm EX-24 6905 Complete submission text file 0001919246-26-000044.txt 13379 Mailing Address 1410 SMYTHE ST DANIEL ISLAND SC 29492 Business Address Plesha Scott M. ( Reporting ) CIK : 0001726687 (see all company filings) Type: 4/A | Act: 34 | File No.: 001-41964 | Film No.: 26829683 Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422 Pelthos Therapeutics Inc. ( Issuer ) CIK : 0001919246 (see all company filings) EIN. : 863335449 | State of Incorp.: NV | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)